• KIEAE Journal
• /
• 제16권5호
• /
• pp.39-45
• /
• 2016

Purpose: The purpose of this study is to analyze the energy saving and cost benefit analysis of the Low-income Energy Efficiency Treatment Program supported by KOREF(Korea Energy Foundation). This program was launched in 2007 and performs building energy retrofit for the low-income and energy poverty houses. Method: Energy simulation and cost benefit analysis were accomplished for the low-income detached houses. The structure of detached house was a lot og block structure, wood frame (single glass) and concrete roof. Baseline model of the low-income detached houses was proposed. Result: Annual heating energy consumptions were decreased by about 3.2% with the window system replacement(Case 1), 9.3% with reinforcement of insulation(Case2), and 12.5% with both(Case 3) compared to those of baseline model. The construction cost will be recouped within 5 years for the Case 1, 3 years for the Case 2, and 3 years for the Case 3. Case 3 was the most cost beneficient construction method in the analyzed cases in this study.

• 대한한의학회지
• /
• 제36권3호
• /
• pp.98-110
• /
• 2015

Objectives: The purpose of this study was to analyze the medical cost of facial paralysis in payer perspective and to estimate the practice pattern of patient using 2011 Health Insurance Review & Assessment Service-National Patients Sample(HIRA-NPS). Methods: Basic statistical system was used for descriptive analysis of NPS dataset. A table for general information (table20) was extracted by disease code, and social demographic characteristics, distribution of the use among inpatients and outpatients, utilization of each kind of medical care institutions, medical cost were analyzed. Subgroup analysis was conducted for assuming the practice pattern of korean medicine and western medicine. Results: A total of 8,219 people and 64,345 claims data were identified as having facial paralysis. Proportion of outpatient was 95.23%, inpatient 0.84% and patient using both services 3.93%. Mean patient charges was 44,229 won per outpatient, 178,886 won per inpatient and 523,542 won per patient using both services. Utilization of korean medical care institutions was 68.81%(claims), 40.46%(patients), utilization of western medical care institutions was 31.19%(claims), 59.54%(patients). The amount charged by korean medical care institutions was 52.61% and western medical care institutions was 47.39%. Cost per claim was higher than those of the korean treatment and cost per patient of western treatment was lower than those of the korean treatment. Conclusions: The research assessed the medical cost and practice pattern associated with facial paralysis. These findings could be used in health care policy and subsequent studies.

• 한국임상약학회지
• /
• 제28권2호
• /
• pp.131-137
• /
• 2018

Background: In South Korea, 22.3% of women ${\geq}50years$ of age and 37% of women ${\geq}70years$ of age visit the doctor to obtain treatment for osteoporosis. According to the analysis of the National Health Insurance Services claim data between 2008 and 2012, the number and incidence of hip and vertebral fractures increased during the same period. Denosumab, a newly marketed medicine in Korea, is the first RANK inhibitor. Methods: A cost-utility analysis was conducted from a societal perspective to prove the superiority of denosumab to alendronate. A Markov cohort model was used to investigate the cost-effectiveness of denosumab. A 6-month cycle length was used in the model, and all patients were individually followed up through the model, from their age at treatment initiation to their time of death or until 100 years of age. The model consisted of eight health states: well; hip fracture; vertebral fracture; wrist fracture; other osteoporotic fracture; post-hip fracture; post-vertebral fracture; and dead. All patients began in the well-health state. In this model, 5% discounted rate, two-year maximum offset time, and persistence were adopted. Results: The total lifetime costs for alendronate and denosumab were USD 5,587 and USD 6,534, respectively. The incremental cost-effectiveness ratio (ICER) for denosumab versus alendronate was USD 20,600/QALY. Given the ICER threshold in Korea, the results indicated that denosumab was remarkably superior to alendronate. Conclusion: Denosumab is a cost-effective alternative to the oral anti-osteoporotic treatment, alendronate, in South Korea.

• 한국임상약학회지
• /
• 제33권1호
• /
• pp.43-50
• /
• 2023

Background and Objective: With the advancement of cancer treatments and increased life expectancy, managing breakthrough cancer pain (BTcP) is essential to improve the quality of life for cancer patients. This study aimed to compare the major rapid onset opioids in Korea based on their characteristics and costs to determine the best option for each patient. Methods: Based on sales information from IQVIA-MIDAS, sublingual fentanyl tablet (SLF), fentanyl buccal tablet (FBT), and oral transmucosal fentanyl citrate (OTFC) were selected as the top three drugs for the treatment of BTcP in Korea, considering them the most comparable drugs. The cost and cost-pain relief ratio of the drugs for short-term (1 month) and long-term (1 year) treatment were compared and the ease of administration based on various factors, including pharmacokinetics, onset of action, and administration procedures were evaluated. Results: SLF was evaluated as the best overall in terms of rapid onset of action, ease of administration, and drug cost and also had the highest market share. SLF had the lowest cost pain relief ratio for both the initial and supplemental treatment for the 1-month pain intensity difference 15 (PID15) ratio. However, for the 1-month PID30 ratio, SLF was not superior to OTFC or FBT. The longer the breakthrough cancer pain duration, the more cost-effective the other rapid onset opioids. Conclusion: The rapid onset opioids that fit the patient's breakthrough cancer pain pattern have the best cost-effectiveness.

• Archives of Plastic Surgery
• /
• 제35권2호
• /
• pp.223-228
• /
• 2008

Purpose: V.A.C. is a new concept which is closed dressing with negative pressure to promote wound healing. It has been widely used as the treatment of chronic and acute wounds such as pressure sores, burns, stasis ulcers, and other complicated wounds. However It has disadvantages such as high cost and the need of specific equipment. In this article, we described new method to overcome these disadvantages. Methods: We made newly innovated equipment with 50 cc syringe and spring to create negative pressure. From May 2006 to May 2007, we applied it to two patients with chronic wound. Results: The treatment period was 5 weeks for one case and 3 weeks for the other case. Both patients were healed completely without admission and wound healing was accelerated. During follow-ups, there were no complications. The mean cost for single dressing was 9,590 won. Conclusion: Modified portable negative therapy using newly innovated equipment could accelerate wound healing better than conventional dressing. It lowers the number of dressings, saves cost of treatment, and enables treatment as outpatient basis.

• 한국농공학회지
• /
• 제39권5호
• /
• pp.64-70
• /
• 1997

Sludge is generated in the process of water and wastewater treatment, and it has been causing various problems environmentally and economically. The firing technology in pottery industry was applied to the sludge treatment, and the final product was called artificial soil. For the production of artificial soil, lime and chabazite was used as additive, and the mixed material was thermally treated in the firing kiln at $300^{\circ}$ temperature for about 15 minutes. The physico-chemical characteristics of the artificial soil was analyzed and it showed that the artificial soil could be used as a soil conditioner for farmland. The concentrations of the toxic heavy metals in the artificial soil were lower than those in the soil quality standard for farmland. It was high in permeability, total nitrogen and total phosphorous concentrations and surface area of the artificial soil compared to the common field soil. Preliminary cost analysis showed that the sludge treatment cost for artificial soil was less than the disposal cost in the current landfill disposal method. This study illustrated that the artificial soil production process can be a feasible alternative for sludge treatment, and produced artificial soil may he applied to farmland without causing significant adverse effect. Further study is recommended for practical application of the system and verification of the longterm effect of the artificial soil on farmland.

• 치위생과학회지
• /
• 제15권6호
• /
• pp.703-711
• /
• 2015

본 연구는 편의 추출된 30대~50대 성인 남녀 266명을 대상으로 치과치료비 본인부담금 스트레스, 비급여 치과치료 건강보험 확대, 민영 치과단독의료보험 가입 의사를 설문조사하였다. 건강보험 비급여 본인부담금 스트레스가 급여 본인부담금 스트레스에 비해 높으며, 교정, 임플란트, 틀니, 보철, 비급여재료 치아우식증 치료 순으로 스트레스 수준이 높았다. 치과치료에 있어서 건강보험확대는 필요하며 필요 순으로는 비급여재료 치아우식증 치료, 보철, 교정 순이었다. 연령제한이 있는 급여항목에 대해서는 적절하다는 응답이 치석제거 57.1%, 틀니 23.3%, 임플란트 14.3%였다. 구강상태가 나쁘다고 응답한 대상자는 급여 본인부담금과 비급여 본인부담금 모두에서 스트레스 정도가 유의하게 높으며 보철, 치아교정에 대한 건강보험 확대요구가 유의하게 높았다. 민영의료보험 가입자 중 치과치료를 보장하는 대상자는 18.3%, 민영 치과단독의료보험에 가입한 가입자는 8.3%였으나, 민영 치과단독의료보험 가입의사는 68.4%였다. 일반적 특성에 따른 민영 치과단독의료보험 가입의사 차이는 나타나지 않았고, 치과치료비의 부담정도와 민영 치과단독의료보험 가입필요 정도의 상관분석 결과, 임플란트 0.408, 비급여 치아우식증 치료는 0.404, 틀니 0.394, 보철치료 0.375, 치아교정 0.313 순으로 나타났다. 따라서, 적기치료가 가능하도록 급여 치과치료 본인부담금에 대한 부담 감소를 위해 치과치료 건강보험 급여 확대, 민영 치과단독의료보험 개발과 이에 따른 정부의 감독이 필요할 것으로 생각되었다.

• 한국병원경영학회지
• /
• 제23권3호
• /
• pp.28-38
• /
• 2018

Purposes: 본 연구는 전립선암 환자의 의료비 지출을 평가하기 위해 남성호르몬 박탈 치료와 근치적 전립선적출술의 비용을 비교하였다. Methods: 본 연구는 스마트 전립선암 데이터베이스(Smart Prostate Cancer Database)의 전립선암 환자 357명의 데이터와 청구데이터베이스에서 의료비 관련 데이터를 도출하였다. 근치적 전립선적출술과 남성호르몬 박탈 치료간 비교를 위해 독립표본 t검정을 실시하였다. 또한 남성호르몬 박탈 치료와 근치적 전립선적출술에 영향을 미치는 요인을 검증하기 위해 다중회귀 분석을 실시하였다. Findings: 치료 후 1년까지 남성호르몬 박탈치료가 근치적 전립선적출술 보다 비용이 낮은 것으로 나타났으며, 치료 후 4년까지 낮게 유지되었다. 그러나 4년이 지나면 남성호르몬 박탈 치료의 누적의료비가 근치적 전립선적출술보다 더 유의미하게 높게 나타났다. 환자의 병기가 높거나 나이가 많은 경우 근치적 전립선적출술보다 남성호르몬 박탈 치료를 할 확률이 더 높았다. Practical Implications: 본 연구는 조기 암 발견이 환자 뿐 아니라 국민건강보험공단의 의료비를 줄일 수 있다는 것을 보여 준다. 또한 의료비를 정확히 평가하기 위해서는 오랜 기간의 정보를 평가해야 하며, 이를 기반으로 평가 및 예측이 필요함을 증명하였다.

• 설비공학논문집
• /
• 제22권1호
• /
• pp.49-55
• /
• 2010

The objectives of this study are to analyze the energy independence plan and to propose a suitable sewage treatment plant in Korea. The total amount of electricity consumption for public sewage treatment plant was estimated as 1,812 GWh in 2007. It was estimated that total 16 sewage treatment plants with renewable energy systems produced electricity of 15 GWh per year, which could replace 0.8% of total electricity used for sewage treatment. It was found that domestic sewage treatment plants with power generation plants by digestion gas were installed in 7 places and produced electricity of 13 GWh per year. It was also found that the power generation plants by digestion gas were the most cost-effective for sewage treatment plant out of the renewable energy systems based on the benefit-cost analysis.

• 척추신경추나의학회지
• /
• 제16권2호
• /
• pp.97-105
• /
• 2021

Objectives This study is aimed to evaluate cost-effectiveness of treatment of Korean Medicine for whiplash associated disorders (WAD) and to suggest the direction of future research. Methods We searched papers in Pubmed database to use some keywords indicating whiplash injury syndrome, treatment of Korean Medicine and cost-effectiveness. After searching, appropriate papers were selected depending on the exclusion criteria. The selected papers were analyzed in the sections of author, publication year, intervention and control groups, outcome measurement, the list including in the cost, cost-effectiveness, cost-utility and study design. Results Four studies about effect of Korean medicine and 3 studies about economic evaluation were finally included. Acupuncture was effective for balance disorder and neck pain. Economic evaluation studies used analytical decision model or cost-consequence analysis. Cost-effectiveness analysis using visual analog scale and cost-utility analysis using quality adjusted life years were performed. Initiating timing of proper management affected the consequence of treatments. Direct and indirect medical costs including supportive devices, and non-medical costs such as litigation were considered. Conclusions We conclude that studies haven't been conducted so far to evaluate the cost-effectiveness of Korean Medicine in whiplash injury syndrome. Thus, future studies are needed in this section.